Related Experiment Video
Updated: Aug 28, 2025

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
Published on: April 1, 2022
Long-Term Outcomes of Cardiovascular Operations in Children With Connective Tissue Disorders
Amanda S Thomas1, Erin E Falk2, Sarah Mahoney3
1Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
Insights
Pediatric cardiac surgery for connective tissue disorders has high long-term cardiovascular mortality. Infantile cases had poor survival, and late deaths in older children highlight the need for lifelong monitoring.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Connective Tissue Disorders
Background:
- Connective tissue disorders frequently cause cardiovascular complications requiring surgical intervention in children.
- Understanding long-term outcomes is crucial for managing these complex pediatric patients.
Purpose of the Study:
- To describe the long-term outcomes of pediatric patients undergoing their first cardiac surgery for connective tissue-related cardiovascular conditions.
- To identify survival rates and causes of late mortality in this specific patient cohort.
Main Methods:
- Retrospective analysis of 103 patients (<21 years) from the Pediatric Cardiac Care Consortium (1982-2003).
- Long-term follow-up through 2019 using National Death Index and Organ Procurement linkage.
- Analysis focused on aortic and atrioventricular valve surgeries.
Main Results:
- Most patients (n=85) had aortic site surgery, often with composite grafts (n=50).
- Among 99 survivors to discharge, 3 infantile patients died before age 4; 29 deaths and 1 transplant occurred in the non-infantile group over a median 19.5-year follow-up.
- Post-discharge survival for non-infantile patients was 92.2% at 10 years, 68.2% at 20 years, and 56.7% at 25 years.
Conclusions:
- Cardiovascular pathology was the primary cause of death in both infantile (100%) and non-infantile (89%) patients post-discharge.
- Significant late mortality underscores the critical need for continuous monitoring and management of pediatric patients with connective tissue disorders undergoing cardiac surgery.
Abstract:
Connective tissue disorders can be associated with significant cardiovascular morbidity needing cardiac surgery during childhood. In this retrospective study, we used the Pediatric Cardiac Care Consortium, a multicenter United States-based registry of pediatric cardiac interventions, to describe the long-term outcomes of patients who underwent their first surgery for connective tissue-related cardiovascular conditions aged <21 years. Between 1982 and 2003, a total of 103 patients were enrolled who underwent cardiac surgery for a connective tissue-related cardiovascular disorder, including 3 severe infantile cases operated on within the first year of life. Most patients underwent aortic site surgery (n = 85) as a composite graft (n = 50), valve-sparing (n = 33), or other aortic surgery (n = 2). The remaining patients underwent atrioventricular valve surgery (mitral 17, tricuspid 1). Of the 99 patients surviving to discharge, 80 (including the 3 infantile) had adequate identifiers for tracking long-term outcomes through 2019 through linkage with the National Death Index and the Organ Procurement. Over a median period of 19.5 years (interquartile range 16.0 to 23.1), 29 deaths and 1 transplant occurred in the noninfantile group, whereas all 3 infantile patients died before the age of 4 years. The postdischarge survival for the noninfantile group was 92.2%, 68.2%, and 56.7% at 10, 20, and 25 years, respectively. Cardiovascular-related pathology contributed to all deaths in the infantile and 89% (n = 27) of deaths for the noninfantile cases after hospital discharge. The significant late attrition from cardiovascular causes emphasizes the need for close monitoring and ongoing management in this population.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

